Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fortin

Showing results (211-220 of 329) with videos related to

Pageof 33
Sort By:
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|November 18, 2000
Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical healthP L Dobkin, D Da Costa, M Dritsa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 28, 2020
Platelets Disseminate Extracellular Vesicles in Lymph in Rheumatoid ArthritisNicolas Tessandier, Imene Melki, Nathalie Cloutier, et al.
The Journal of Rheumatology|July 16, 1999
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study GroupA E Clarke, M A Petri, S Manzi, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitorsR W Friesen, C Brideau, C C Chan, et al.
Vaccines|February 26, 2025
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) StudyJeremiah Tan, Sasha Bernatsky, Jennifer L F Lee, et al.
ACR Open Rheumatology|July 2, 2024
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort StudyRami Habib, Roya M Dayam, Carol Hitchon, et al.
Lupus Science & Medicine|June 14, 2022
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry')Zeynep Belce Erton, Ecem Sevim, Guilherme Ramires de Jesús, et al.
Arthritis Care & Research|February 13, 2013
Association of smoking with cutaneous manifestations in systemic lupus erythematosusJosiane Bourré-Tessier, Christine A Peschken, Sasha Bernatsky, et al.
Journal of Medicinal Chemistry|September 27, 1996
Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stabilityD Delorme, Y Ducharme, C Brideau, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 11, 2002
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosusPatricia L Dobkin, Deborah Da Costa, Lawrence Joseph, et al.
Pageof 33

Showing results (211-220 of 329) with videos related to

Sort By:
Pageof 33
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|November 18, 2000
Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical healthP L Dobkin, D Da Costa, M Dritsa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 28, 2020
Platelets Disseminate Extracellular Vesicles in Lymph in Rheumatoid ArthritisNicolas Tessandier, Imene Melki, Nathalie Cloutier, et al.
The Journal of Rheumatology|July 16, 1999
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study GroupA E Clarke, M A Petri, S Manzi, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitorsR W Friesen, C Brideau, C C Chan, et al.
Vaccines|February 26, 2025
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) StudyJeremiah Tan, Sasha Bernatsky, Jennifer L F Lee, et al.
ACR Open Rheumatology|July 2, 2024
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort StudyRami Habib, Roya M Dayam, Carol Hitchon, et al.
Lupus Science & Medicine|June 14, 2022
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry')Zeynep Belce Erton, Ecem Sevim, Guilherme Ramires de Jesús, et al.
Arthritis Care & Research|February 13, 2013
Association of smoking with cutaneous manifestations in systemic lupus erythematosusJosiane Bourré-Tessier, Christine A Peschken, Sasha Bernatsky, et al.
Journal of Medicinal Chemistry|September 27, 1996
Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stabilityD Delorme, Y Ducharme, C Brideau, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 11, 2002
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosusPatricia L Dobkin, Deborah Da Costa, Lawrence Joseph, et al.
Pageof 33